Puybasset L, Béa M L, Simon L, Ghaleh B, Giudicelli J F, Berdeaux A
Département de pharmacologie, faculté de médecine Paris-Sud, Le Kremlin-Bicêtre.
Arch Mal Coeur Vaiss. 1995 Aug;88(8):1217-21.
Acute and chronic administration of nitric oxide (NO) synthase (NOS) inhibitors increase mean arterial blood pressure (MAP) in rats but their hemodynamic effects in other species remain unknown. Moreover, the role of NO in the control of exercise-induced vasodilation is still debated. To answer these questions, six dogs were instrumented for the continuous measurement of cardiac output (CO, electromagnetic flow probe on the aorta), MAP (aortic catheter) and left ventricular pressure (Konigsberg gauge). Total peripheral resistance (TPR) was calculated as MAP/CO ratio and dP/dt was used as an index of cardiac inotropism. The dogs were treated from day 0 (D0) to 7 (D7) by the NOS inhibitor, N omega-nitro-L-arginine (L-NNA), 20 mg/kg/day (IV). Such a dose regimen resulted in NOS inhibition evidenced (a) in vivo by a reduction of the hypotensive responses to graded doses of acetylcholine and bradykinin, (b) ex vivo by a decrease in the relaxation of the femoral artery to acetylcholine (EC 50 = 2.2 +/- 0.6 10(-7) M after L-NNA vs 2.2 +/- 0.8 10(-8) M in controls). One month after instrumentation, the dogs being conscious, MAP measured at rest remained unchanged following one week L-NNA treatment (from 90 +/- 2 at D0 to 91 +/- 5 mmHg at D7). However, TPR increased (from 3,600 +/- 290 at D0 to 6,300 +/- 510 dyn.s.cm-5 at D7) and CO decreased (from 2.1 +/- 0.2 at D0 to 1.2 +/- 0.1 l/min at D7) (all p < 0.01), partly as the result of a marked bradycardia (from 100 +/- 7 at D0 to 60 +/- 7 beats/min at D7). L-NNA induced-increase in TPR was completely reversed by a bolus injection of nitroglycerin (10 micrograms/kg). During treadmill exercise (12 km/h), heart rate (251 +/- 9 at D0 vs 226 +/- 11 beats/min at D7), CO (6.3 +/- 0.9 at D0 vs 4.3 +/- 0.7 l/min at D7) and stroke volume remained significantly lower, and TPR significantly higher (1,662 +/- 278 at D0 vs 2,621 +/- 489 dyn.s.cm-5 at D7) after L-NNA than in the control state. Thus, NOS inhibition in resting conscious dogs by L-NNA markedly increases peripheral resistance but does not increase arterial pressure. In addition, L-NNA blunts both exercise-induced peripheral vasodilation and increase in cardiac output, despite metabolic vasodilation.
急性和慢性给予一氧化氮(NO)合酶(NOS)抑制剂可使大鼠平均动脉血压(MAP)升高,但其在其他物种中的血流动力学效应仍不清楚。此外,NO在运动诱导的血管舒张控制中的作用仍存在争议。为了回答这些问题,对6只犬进行了仪器植入,以连续测量心输出量(CO,主动脉上的电磁流量探头)、MAP(主动脉导管)和左心室压力(康氏压力计)。总外周阻力(TPR)计算为MAP/CO比值,dP/dt用作心肌收缩力指标。从第0天(D0)至第7天(D7),给犬静脉注射NOS抑制剂Nω-硝基-L-精氨酸(L-NNA),剂量为20mg/kg/天。这样的剂量方案导致NOS受到抑制,证据如下:(a)在体内,对分级剂量的乙酰胆碱和缓激肽的降压反应降低;(b)在体外,股动脉对乙酰胆碱的舒张作用减弱(L-NNA处理后EC50 = 2.2±0.6×10⁻⁷M,而对照组为2.2±0.8×10⁻⁸M)。仪器植入一个月后,犬处于清醒状态,L-NNA治疗一周后静息时测量的MAP保持不变(从D0时的90±2mmHg升至D7时的91±5mmHg)。然而,TPR升高(从D0时的3600±290升至D7时的6300±510dyn·s·cm⁻⁵),CO降低(从D0时的2.1±0.2降至D7时的1.2±0.1l/min)(所有p<0.01),部分原因是明显的心动过缓(从D0时的100±7降至D7时的60±7次/分钟)。静脉注射硝酸甘油(10μg/kg)可完全逆转L-NNA诱导的TPR升高。在跑步机运动(12km/h)期间,L-NNA处理后的心率(D0时为251±9次/分钟,D7时为226±11次/分钟)、CO(D0时为6.3±0.9l/min,D7时为4.3±0.7l/min)和每搏输出量仍显著降低,TPR显著升高(D0时为1662±278dyn·s·cm⁻⁵,D7时为2621±489dyn·s·cm⁻⁵),高于对照状态。因此,L-NNA对清醒静息犬的NOS抑制可显著增加外周阻力,但不增加动脉血压。此外,尽管存在代谢性血管舒张,L-NNA仍可减弱运动诱导的外周血管舒张和心输出量增加。